ONC
BeOne Medicines Ltd ADR
3월 13일 4:00 PM ET (한국 3/14 05:00)
$284.05
-1.25 ▼ -0.44%
🌙 3월 13일 7:54 PM ET (한국 3/14 08:54)
$284.05
+0.00 +0.00%
| Index | - | P/E | 112.58 | EPS (ttm) | 2.52 | Insider Own | 0.5% | Shs Outstand | 0.11B | Perf Week | -5.67% |
| Market Cap | 31.49B | Forward P/E | 29.68 | EPS next Y | 56.57% | Insider Trans | -22.99% | Shs Float | 0.11B | Perf Month | -19.14% |
| Enterprise Value | 28.90B | PEG | 0.42 | EPS next Q | 1.01 | Inst Own | 30.31% | Short Float | 1.35% | Perf Quarter | -11.97% |
| Income | 0.29B | P/S | 5.88 | EPS this Y | 132.41% | Inst Trans | 0.6% | Short Ratio | 5.19 | Perf Half Y | -15.38% |
| Sales | 5.36B | P/B | 7.22 | EPS next 5Y | 70.4% | ROA | 4.06% | Short Interest | 1.49M | Perf YTD | -6.5% |
| Book/sh | 39.34 | P/C | 6.86 | EPS past 3/5Y | - | ROE | 7.48% | 52W High | -26.26% ($385.22) | Perf Year | 11.58% |
| Cash/sh | 41.4 | P/FCF | 33.35 | Sales past 3/5Y | 55.88% 76.88% | ROIC | 4.62% | 52W Low | 44.59% ($196.45) | Perf 3Y | 27.82% |
| Dividend Est. | - | EV/EBITDA | 48.93 | EPS Y/Y TTM | 142.8% | Gross Margin | 85.28% | Volatility(W/M) | 2.32% 2.93% | Perf 5Y | -11.7% |
| Dividend TTM | - | EV/Sales | 5.39 | Sales Y/Y TTM | 40.76% | Oper. Margin | 8.37% | ATR (14) | 11.36 | Perf 10Y | 918.83% |
| Dividend Ex-Date | - | Quick Ratio | 3.08 | EPS Q/Q | 140.65% | Profit Margin | 5.37% | RSI (14) | 29.53 | Recom | 1.19 |
| Dividend Gr. 3/5Y | - | Current Ratio | 3.41 | Sales Q/Q | 33.9% | SMA20 | -12.44% ($324.41) | Beta | 0.55 | Target Price | $417.04 |
| Payout | - | Debt/Eq | 0.46 | Earnings | 2000000 | SMA50 | -14.73% ($333.12) | Rel Volume | 0.8 | Prev Close | $285.3 |
| Employees | 12000 | LT Debt/Eq | 0.43 | EPS/Sales Surpr. | -51.76% 2.24% | SMA200 | -9.28% ($313.11) | Avg Volume(3M) | 0.29M | Price | $284.05 |
| IPO | 2016/2/3 | Option/Short | Yes/Yes | Trades | 6540 | Volume | 229,106 | Change | -0.44% |
뉴스 로딩 중...